05 May 2017 EMA/290427/2017 Procedure Management and Committees Support

List of nationally authorised medicinal products

Active substance: oxcarbazepine

Procedure no.: PSUSA/00002235/201608

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country) Timox 300 mg Filmtabletten Timox 600 mg Filmtabletten Timox 150 mg Filmtabletten Timox 60 mg/ml Suspension zum Einnehmen Timox extent 150 mg Tabletten mit veränderter Wirkstofffreisetzung Timox extent 300 mg Tabletten mit veränderter Wirkstofffreisetzung Timox extent 600 mg Tabletten mit veränderter Wirkstofffreisetzung Apydan extent 150 mg Tabletten mit veränderter Wirkstofffreisetzung Apydan extent 300 mg Tabletten mit veränderter Wirkstofffreisetzung Apydan extent 600 mg Tabletten mit veränderter Wirkstofffreisetzung Trileptal 150 mg Filmtabletten Trileptal 300 mg Filmtabletten Trileptal 60 mg/ml Suspension zum Einnehmen Trileptal 600 mg Filmtabletten List of nationally authorised medicinal products EMA/290427/2017

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state DESITIN ARZNEIMITTEL DESITIN ARZNEIMITTEL DESITIN ARZNEIMITTEL DESITIN ARZNEIMITTEL

Member State where product is authorised

DE/H/4778/002

49261.01.00

DE/H/4778/003

49261.02.00

DE/H/4778/001

49261.00.00

DE/H/4778/004

52125.00.00

not available

65230.00.00

DESITIN ARZNEIMITTEL GMBH

DE

not available

65231.00.00

DESITIN ARZNEIMITTEL GMBH

DE

not available

65232.00.00

DESITIN ARZNEIMITTEL GMBH

DE

not available

65225.00.00

DESITIN ARZNEIMITTEL GMBH

DE

not available

65226.00.00

DESITIN ARZNEIMITTEL GMBH

DE

not available

65227.00.00

DESITIN ARZNEIMITTEL GMBH

DE

DK/H/0168/001

BE208993

BE

DK/H/0168/002

BE209002

DK/H/0168/004

BE227342

NOVARTIS PHARMA N.V. NOVARTIS PHARMA N.V. NOVARTIS PHARMA N.V.

DK/H/0168/003

BE209011

NOVARTIS PHARMA N.V.

BE

GMBH GMBH GMBH GMBH

DE DE DE DE

BE BE

Page 2/12

Product Name (in authorisation country) Trileptal 300 mg filmom oblozene tablete Trileptal 300 mg filmom oblozene tablete Trileptal 300 mg filmom oblozene tablete Trileptal 300 mg filmom oblozene tablete Trileptal 600 mg filmom oblozene tablete Trileptal 600 mg filmom oblozene tablete Trileptal 600 mg filmom oblozene tablete Trileptal 600 mg filmom oblozene tablete TRILEPTAL 300 MG COMPRIMATE FILMATE TRILEPTAL 300 MG COMPRIMATE FILMATE TRILEPTAL 300 MG COMPRIMATE FILMATE TRILEPTAL 300 MG COMPRIMATE FILMATE TRILEPTAL 300 MG COMPRIMATE FILMATE TRILEPTAL 600 MG COMPRIMATE FILMATE TRILEPTAL 600 MG COMPRIMATE FILMATE TRILEPTAL 600 MG COMPRIMATE FILMATE TRILEPTAL 600 MG COMPRIMATE FILMATE

List of nationally authorised medicinal products EMA/290427/2017

MRP/DCP Authorisation number

National Authorisation Number

DK/H/0168/002

HR-H-309957904-02

DK/H/0168/002

HR-H-309957904-03

DK/H/0168/002

HR-H-309957904-04

DK/H/0168/002

HR-H-309957904-05

DK/H/0168/003

HR-H-007294503-02

DK/H/0168/003

HR-H-007294503-03

DK/H/0168/003

HR-H-007294503-04

DK/H/0168/003

HR-H-007294503-05

not available

9041/2016/01

not available

9041/2016/02

not available

9041/2016/03

not available

9041/2016/04

not available

9041/2016/05

not available

9042/2016/01

not available

9042/2016/02

not available

9042/2016/03

not available

9042/2016/04

MAH of product in the member state NOVARTIS D.O.O. NOVARTIS D.O.O. NOVARTIS D.O.O. NOVARTIS D.O.O. NOVARTIS D.O.O. NOVARTIS D.O.O. NOVARTIS D.O.O. NOVARTIS D.O.O. NOVARTIS GMBH NOVARTIS GMBH NOVARTIS GMBH NOVARTIS GMBH NOVARTIS GMBH NOVARTIS GMBH NOVARTIS GMBH NOVARTIS GMBH NOVARTIS GMBH

Member State where product is authorised

HRVATSKA

HR

HRVATSKA

HR

HRVATSKA

HR

HRVATSKA

HR

HRVATSKA

HR

HRVATSKA

HR

HRVATSKA

HR

HRVATSKA

HR

PHARMA

RO

PHARMA

RO

PHARMA

RO

PHARMA

RO

PHARMA

RO

PHARMA

RO

PHARMA

RO

PHARMA

RO

PHARMA

RO

Page 3/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

TRILEPTAL 600 MG COMPRIMATE FILMATE TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 150 MG TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 150 MG TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 300 MG TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 300 MG TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 300 MG TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 600 MG TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 600 MG TRILEPTAL® ΕΠΙΚΑΛΥΜΈΝΑ ΜΕ ΛΕΠΤΌ ΥΜΈΝΙΟ ΔΙΣΚΊΑ 600 MG TRILEPTAL® 60 MG/ML ΠΌΣΙΜΟ ΕΝΑΙΏΡΗΜΑ TRILEPTAL 600 MG FILMCOATED TABLETS

not available

9042/2016/05

DK/H/0168/001

198880301

DK/H/0168/001

MAH of product in the member state

Member State where product is authorised

NOVARTIS PHARMA GMBH NOVARTIS (HELLAS) S.A.C.I.

RO

198880302

NOVARTIS (HELLAS) S.A.C.I.

GR

DK/H/0168/002

198880401

NOVARTIS (HELLAS) S.A.C.I.

GR

DK/H/0168/002

198880402

NOVARTIS (HELLAS) S.A.C.I.

GR

DK/H/0168/002

198880403

NOVARTIS (HELLAS) S.A.C.I.

GR

DK/H/0168/003

198880501

NOVARTIS (HELLAS) S.A.C.I.

GR

DK/H/0168/003

198880502

NOVARTIS (HELLAS) S.A.C.I.

GR

DK/H/0168/003

198880503

NOVARTIS (HELLAS) S.A.C.I.

GR

DK/H/0168/004

198880601

GR

not available

18464

TRILEPTAL 150 MG FILMCOATED TABLETS

not available

19109

TRILEPTAL 300 MG FILM-

not available

18463

NOVARTIS (HELLAS) S.A.C.I. NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS

List of nationally authorised medicinal products EMA/290427/2017

GR

CY CY CY

Page 4/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

COATED TABLETS Trileptal 150 mg Comprimidos revestidos por película Trileptal 150 mg Comprimidos revestidos por película Trileptal 150 mg Comprimidos revestidos por película Trileptal 150 mg Comprimidos revestidos por película Trileptal 150 mg Comprimidos revestidos por película Trileptal 300 mg Comprimidos revestidos por película Trileptal 300 mg Comprimidos revestidos por película Trileptal 300 mg Comprimidos revestidos por película Trileptal 300 mg Comprimidos revestidos por película Trileptal 300 mg Comprimidos revestidos por película Trileptal 60 mg/ml Suspensão oral

List of nationally authorised medicinal products EMA/290427/2017

DK/H/0168/001

3127081

DK/H/0168/001

3127180

DK/H/0168/001

3127289

DK/H/0168/001

3127388

DK/H/0168/001

3127487

DK/H/0168/002

3127586

DK/H/0168/002

3127685

DK/H/0168/002

3127784

DK/H/0168/002

3127883

DK/H/0168/002

3127982

DK/H/0168/004

3732989

MAH of product in the member state PHARMACEUTICALS UK LIMITED NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A.

Member State where product is authorised

PT PT PT PT PT PT PT PT PT PT PT

Page 5/12

Product Name (in authorisation country) Trileptal 600 mg Comprimidos revestidos por película Trileptal 600 mg Comprimidos revestidos por película Trileptal 600 mg Comprimidos revestidos por película Trileptal 600 mg Comprimidos revestidos por película Trileptal 600 mg Comprimidos revestidos por película Trileptal 150 mg plėvele dengtos tabletės TRILEPTAL 150 mg tablett, filmdragerad Trileptal 150 mg tabletti, kalvopäällysteinen TRILEPTAL® 300 MG APVALKOTAS TABLETES Trileptal 300 mg plėvele dengtos tabletės TRILEPTAL 300 mg tablett, filmdragerad Trileptal 300 mg tabletti, kalvopäällysteinen Trileptal 60 mg/ml oraalisuspensio Trileptal 60 mg/ml oral suspension TRILEPTAL® 600 MG APVALKOTAS TABLETES List of nationally authorised medicinal products EMA/290427/2017

MRP/DCP Authorisation number

National Authorisation Number

DK/H/0168/003

3128089

DK/H/0168/003

3128188

DK/H/0168/003

3128287

DK/H/0168/003

3128386

DK/H/0168/003

3128485

not available

LT/1/97/1473/001

DK/H/0168/001

14797

DK/H/0168/001

14797

not available

99-0279

not available

LT/1/97/1473/002

DK/H/0168/002

14798

DK/H/0168/002

14798

DK/H/0168/004

16570

DK/H/0168/004

16570

not available

99-0280

MAH of product in the member state NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY

Member State where product is authorised PT PT PT PT PT LT FI FI LV LT FI FI FI FI LV

Page 6/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

Trileptal 600 mg plėvele dengtos tabletės TRILEPTAL 600 mg tablett, filmdragerad Trileptal 600 mg tabletti, kalvopäällysteinen Trileptal 300 mg comprimidos recubiertos con película Trileptal 600 mg comprimidos recubiertos con película Trileptal

not available

LT/1/97/1473/003

DK/H/0168/003

14799

DK/H/0168/003

14799

DK/H/0168/002

63.093

DK/H/0168/003

MAH of product in the member state

Member State where product is authorised

NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FINLAND OY NOVARTIS FARMACÉUTICA S.A.

LT

63.095

NOVARTIS FARMACÉUTICA S.A.

ES

DK/H/0168/001

30413

DK

Trileptal

DK/H/0168/002

30414

Trileptal

DK/H/0168/003

30415

Trileptal, oral suspension

DK/H/0168/004

31743

Trileptal® 150 mg Filmtabletten Trileptal 150 mg, filmomhulde tabletten Trileptal 300 mg filmomhulde tabletten Trileptal® 300 mg Filmtabletten Trileptal 300 mg tabletki powlekane TRILEPTAL 300 MG FILMTABLETTA TRILEPTAL 300 MG FILMTABLETTA

DK/H/0168/001

47357.00.00

DK/H/0168/001

RVG 24750

DK/H/0168/002

RVG 24751

DK/H/0168/002

47357.01.00

not available

8256

not available

OGYI-T-6308/01

not available

OGYI-T-6308/02

NOVARTIS HEALTHCARE A/S NOVARTIS HEALTHCARE A/S NOVARTIS HEALTHCARE A/S NOVARTIS HEALTHCARE A/S NOVARTIS PHARMA GMBH NOVARTIS PHARMA B.V. NOVARTIS PHARMA B.V. NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O. O. NOVARTIS HUNGÁRIA KFT. PHARMA NOVARTIS HUNGÁRIA KFT. PHARMA

List of nationally authorised medicinal products EMA/290427/2017

FI FI ES

DK DK DK DE NL NL DE PL HU HU

Page 7/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Trileptal 60 mg/ml, suspensie voor oraal gebruik Trileptal® 60 mg/ml Suspension zum Einnehmen Trileptal 600 mg filmomhulde tabletten TRILEPTAL 600 MG FILMTABLETTA TRILEPTAL 600 MG FILMTABLETTA Trileptal® 600 mg Filmtabletten Trileptal 600 mg tabletki powlekane Trileptal, 60 mg/ml, zawiesina doustna TRILEPTAL 150 MG TABLETKI POWLEKANE TRILEPTAL 60 MG/ML ORAL SUSPENSION

DK/H/0168/004

RVG 26830

NOVARTIS PHARMA B.V.

NL

DK/H/0168/004

51794.00.00

NOVARTIS PHARMA GMBH

DE

DK/H/0168/003

RVG 24752

NL

not available

OGYI-T-6308/03

not available

OGYI-T-6308/04

DK/H/0168/003

47357.02.00

not available

8257

not available

7471

not available

8255

not available

088/04301

TRILEPTAL 150 MG FILMCOATED TABLETS

not available

088/04302

TRILEPTAL 300 MG FILMCOATED TABLETS

not available

088/04303

TRILEPTAL 600 MG FILMCOATED TABLETS

not available

088/04304

TRILEPTAL 150 MG – FILMTABLETTEN

DK/H/0168/001

1-23489

NOVARTIS PHARMA B.V. NOVARTIS HUNGÁRIA KFT. PHARMA NOVARTIS HUNGÁRIA KFT. PHARMA NOVARTIS PHARMA GMBH NOVARTIS POLAND SP. Z O. O. NOVARTIS POLAND SP. Z O. O. NOVARTIS POLAND SP. Z O. O. NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMA GMBH

List of nationally authorised medicinal products EMA/290427/2017

HU HU DE PL PL PL MT MT MT MT AT

Page 8/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

TRILEPTAL® 150 MG FILM-COATED TABLETS

DK/H/0168/001

PL 00101/0581

Trileptal 150 mg filmdragerade tabletter Trileptal 150mg comprimé pelliculé Trileptal 150mg comprimé pelliculé Trileptal 150 mg filmcoated tablets

DK/H/0168/001

15781

DK/H/0168/001

3400935357014

DK/H/0168/001

3400935357182

DK/H/0168/001

PA 13/92/1

TRILEPTAL 300 MG – FILMTABLETTEN Trileptal 300 mg comprimé pelliculé Trileptal 300 mg comprimé pelliculé TRILEPTAL® 300 MG FILM-COATED TABLETS

DK/H/0168/002

1-23490

DK/H/0168/002

3400935357243

DK/H/0168/002

3400935357304

DK/H/0168/002

PL 00101/0582

Trileptal 300 mg Filmcoated tablets

DK/H/0168/002

PA 13/92/2

Trileptal 300 mg filmdragerade tabletter TRILEPTAL 60 MG/ML SUSPENSION ZUM EINNEHMEN Trileptal 60 mg/ml oral suspension TRILEPTAL 600 MG – FILMTABLETTEN TRILEPTAL® 600 MG FILM-COATED TABLETS

DK/H/0168/002

15782

DK/H/0168/004

1-24351

DK/H/0168/004

17348

DK/H/0168/003

1-23491

DK/H/0168/003

PL 00101/0583

List of nationally authorised medicinal products EMA/290427/2017

MAH of product in the member state

Member State where product is authorised

NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS SVERIGE AB NOVARTIS PHARMA S.A.S. NOVARTIS PHARMA S.A.S. NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMA GMBH NOVARTIS PHARMA S.A.S. NOVARTIS PHARMA S.A.S. NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS SVERIGE AB NOVARTIS PHARMA GMBH

UK

NOVARTIS SVERIGE AB NOVARTIS PHARMA GMBH NOVARTIS PHARMACEUTICALS

SE

SE FR FR IE AT FR FR UK IE SE AT

AT UK

Page 9/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

UK LIMITED Trileptal 600 mg filmdragerade tabletter TRILEPTAL 600 MG FILMCOATED TABLETS

DK/H/0168/003

15783

DK/H/0168/003

PA 13/92/3

Trileptal 600mg, comprimé pelliculé Trileptal 600mg, comprimé pelliculé TRILEPTAL 60 mg/ml, suspension buvable Trileptal Oral Solution 60 mg/ml

DK/H/0168/003

3400935357472

DK/H/0168/003

3400935357533

DK/H/0168/004

3400935790125

DK/H/0168/004

PA 13/92/4

Trileptal 60 mg/ml Oral Suspension

not available

19494

Trileptal® 60 mg/ml Oral Suspension.

DK/H/0168/004

PL 00101/0631

Trileptal 150 mg filmomhulde tabletten Trileptal 150 mg, comprimés pelliculés TRILEPTAL 300 MG FILMOM OBALENÉ TABLETY Trileptal 60 mg/ml suspensión oral Trileptal 60 mg/ml, suspensie voor oraal gebruik Trileptal 60 mg/ml,

DK/H/0168/001

BE208993

DK/H/0168/001

BE208993

not available

21/0336/00-S

DK/H/0168/004

64.398

DK/H/0168/004

BE227342

DK/H/0168/004

BE227342

List of nationally authorised medicinal products EMA/290427/2017

NOVARTIS SVERIGE AB NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMA S.A.S. NOVARTIS PHARMA S.A.S. NOVARTIS PHARMA S.A.S. NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED NOVARTIS PHARMA N.V. NOVARTIS PHARMA N.V. NOVARTIS, S.R.O.

SE

NOVARTIS FARMACÉUTICA S.A. NOVARTIS PHARMA N.V.

ES

NOVARTIS PHARMA

BE

IE FR FR FR IE CY UK BE BE SK

BE

Page 10/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

suspension buvable Trileptal 600 mg filmomhulde tabletten Trileptal 600 mg, comprimés pelliculés Trileptal 150 mg filmuhúðaðar töflur Trileptal 300 mg filmuhúðaðar töflur Trileptal 60 mg/ml mixtúra, dreifa Trileptal 600 mg filmuhúðaðar töflur Trileptal 150 mg filmdrasjerte tabletter Trileptal 300 mg filmdrasjerte tabletter Trileptal 60 mg/ml mikstur, suspensjon Trileptal 600 mg filmdrasjerte tabletter Trileptal 300 mg filmomhulde tabletten Trileptal 300 mg, comprimés pelliculés Trileptal 150 mg õhukese polümeerikattega tabletid Trileptal 300 mg õhukese polümeerikattega tabletid Trileptal 600 mg õhukese polümeerikattega tabletid Trileptal 300 mg filmom oblozene tablete Trileptal 60 mg/ml oralna

List of nationally authorised medicinal products EMA/290427/2017

MAH of product in the member state

Member State where product is authorised

N.V. DK/H/0168/003

BE209011

BE

99-315

NOVARTIS PHARMA N.V. NOVARTIS PHARMA N.V. NOVARTIS HEALTHCARE A/S NOVARTIS HEALTHCARE A/S NOVARTIS HEALTHCARE A/S NOVARTIS HEALTHCARE A/S NOVARTIS NORGE AS

DK/H/0168/003

BE209011

DK/H/0168/001

IS/1/00/004/01

DK/H/0168/002

IS/1/00/004/02

DK/H/0168/004

IS/1/01/039/01

DK/H/0168/003

IS/1/00/004/03

not available not available

99-316

NOVARTIS NORGE AS

NO

not available

00-8131

NOVARTIS NORGE AS

NO

not available

99-317

NOVARTIS NORGE AS

NO

DK/H/0168/002

BE209002

PHARMA

BE

DK/H/0168/002

BE209002

PHARMA

BE

not available

346401

FINLAND

EE

not available

346501

FINLAND

EE

not available

346601

FINLAND

EE

DK/H/0168/002

HR-H-309957904-01

HRVATSKA

HR

DK/H/0168/004

HR-H-061545230-01

NOVARTIS N.V. NOVARTIS N.V. NOVARTIS OY NOVARTIS OY NOVARTIS OY NOVARTIS D.O.O. NOVARTIS

HRVATSKA

HR

BE IS IS IS IS NO

Page 11/12

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

suspenzija Trileptal 600 mg filmom oblozene tablete

List of nationally authorised medicinal products EMA/290427/2017

MAH of product in the member state

Member State where product is authorised

D.O.O. DK/H/0168/003

HR-H-007294503-01

NOVARTIS HRVATSKA D.O.O.

HR

Page 12/12

oxcarbazepine PSUSA 002235-201608 - European Medicines Agency

May 5, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 65230.00.00.

172KB Sizes 22 Downloads 183 Views

Recommend Documents

PSUSA-00010225-201710 - European Medicines Agency - europa.eu
Jun 14, 2018 - Page 2/3. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Glipizide - PSUSA-00001535-201601 ... - European Medicines Agency
Sep 29, 2016 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency ... Product Name (in authorisation country). MRP/ ...

PSUSA/00003175/201703 - European Medicines Agency - europa.eu
Dec 13, 2017 - SHIRE PHARMACEUTICAL. CONTRACTS LIMITED. HU. Fosrenol 750 mg tyggetablett. SE/H/0481/003. 06-4023. SHIRE PHARMACEUTICAL.

PSUSA/00000266/201710 - European Medicines Agency - europa.eu
Jun 14, 2018 - Malarone Paediatric, 62,5 mg/25 mg õhukese ... MALARONE 62,5 mg/25 .... PL. Malarone 250 mg/100 mg comprimidos revestidos por película.

vinorelbine PSUSA-00003124-201704 ... - European Medicines Agency
Nov 30, 2017 - List of nationally authorised medicinal products. EMA/795271/2017. Page 2/9. Product Name (in authorisation country). MRP/DCP Authorisation number. National. Authorisation Number. MAH of product in the member state. Member State where

PSUSA - European Medicines Agency - Europa EU
A1. 10/02/2017. 11/04/2017. 11/05/2017. 29/05/2017. 09/06/2017. 14/06/2017. 16/06/2017. 22/06/2017. A2. 09/03/2017. 08/05/2017. 07/06/2017. 22/06/2017. 06/07/2017. 11/07/2017. 14/07/2017. 20/07/2017. A3. A4. 05/05/2017. 04/07/2017. 03/08/2017. 18/08/

lovastatin - PSUSA 00010051 201607 - European Medicines Agency
Mar 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency, 2017. ... Product Name (in authorisation country).

PSUSA-00010484-201611 - European Medicines Agency - Europa EU
Jul 6, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/contact. © European ...

PSUSA-00000284-201611 - European Medicines Agency - Europa EU
Sep 13, 2017 - Authorisation number. National Authorisation Number. MAH of product in the member state. Member State where product is authorised. ENTEROGERMINA 6 miliardi/2 g polvere per sospensione orale not available. 013046103. SANOFI SPA. IT. NOR

PSUSA/00000557/201701 - European Medicines Agency - Europa EU
28 Sep 2017 - Active substance(s): carbomers. Procedure No.: PSUSA/00000557/201701 .... 360 845-2. LABORATOIRES THEA. FR. SICCAFLUID 2,5 mg/g, gel ophtalmique en récipient unidose. FR/H/0118/002. 360 847-5. LABORATOIRES THEA. FR. SICCAFLUID 2,5 mg/g

PSUSA/00000295/201712 - European Medicines Agency - Europa EU
Jul 12, 2018 - Bambec Tablets 10 mg not available. PL 17901/0103. ASTRAZENECA UK LIMITED. UK. Bambec 20 mg tabletter not available. 11261.

PSUSA/00001351/201709 - European Medicines Agency - Europa EU
May 30, 2018 - SE. Pepcidtwo chewable tablet not available. PL 15513/0348. MCNEIL PRODUCTS LIMITED UK. Pepcidtwo chewable tablet not available.

PSUSA/00001798/201703 - European Medicines Agency - Europa EU
Nov 30, 2017 - Page 2/8. Product Name. (in authorisation country). MRP/DCP Authorisation. Number. National Authorisation. Number. MAH of product in the Member. State. Member State where product is authorised. Sporanox 10 ... Trisporal O.S.-drank 10 m

PSUSA/00002972/201610 - European Medicines Agency - Europa EU
Jun 9, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

PSUSA/00000906/201705 - European Medicines Agency - Europa EU
Jan 11, 2018 - not available. 023777030. BAYER SPA. IT. Gynofen 35® not available. 39943/16-9-2009. BAYER HELLAS SA. GR. Dianette 2mg/35microgram.

PSUSA/00001484/201703 - European Medicines Agency - Europa EU
Oct 26, 2017 - MRP/DCP Authorisation number. National Authorisation Number. MAH of product in the member state. Member State where product is authorised obložene tablete. OPERATIONS LUXEMBOURG S.A.. FROTAN 2,5 mg filmsko obložene tablete. FR/H/0199

PSUSA/00000187/201703 - European Medicines Agency - Europa EU
Oct 26, 2017 - Flemoxin 250 mg/5 ml. Pulver zur Herstellung einer Suspension zum. Einnehmen not available. BE126987. ASTELLAS PHARMA B.V.,. OFFICE BE. BE ..... 365 824-3. SANDOZ. FR. AMOXICILLINE SANDOZ. 500 mg, gélule. NL 21558. 34009 367 960 1 0.

PSUSA/00009197/201706 - European Medicines Agency - Europa EU
Feb 21, 2018 - 34009 352 558 8 4. ROCHE. FR. ROFERON-A 4,5 millions d'unités internationales (UI), solution injectable en seringue préremplie. NL/H/0028/012. 34009 352 560 2 7. ROCHE. FR. Roferon-A 4,5 millions d'unités internationales (MUI), solu

PSUSA/00010078/201703 - European Medicines Agency - Europa EU
Nov 30, 2017 - Ampres 10 mg/ml solution for injection. DE/H/2866/001. PL 46926/0001. SINTETICA LIMITED. UK. Ampres 10 mg/ml solution for injection. DE/H/2866/001. PL 46926/0001. SINTETICA LIMITED. UK. Ampres 10mg/ml solución inyectable. DE/H/2866/00

PSUSA/00010080/201707 - European Medicines Agency - Europa EU
Apr 12, 2018 - Human Medicines Evaluation Division. List of nationally authorised medicinal products ... List of nationally authorised medicinal products. EMA/234056/2018. Page 3/4. Product Name (in authorisation country). MRP/DCP Authorisation numbe

PSUSA/00002947/201612 - European Medicines Agency - Europa EU
Sep 1, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © European ...

PSUSA/00002024/201710 - European Medicines Agency - Europa EU
Jun 14, 2018 - Medikinet CR 10 mg hörð hylki með breyttan losunarhraða. DE/H/0690/004/E/001. IS/1/14/087/005. MEDICE ARZNEIMITTEL. PÜTTER GMBH ...

PSUSA/00010510/201701 - European Medicines Agency - Europa EU
Sep 28, 2017 - 34009 335 289 2 8. BOUCHARA RECORDATI. FR. ABUFENE 400 mg, comprimé not available. 34009 300 027 1 1. BOUCHARA RECORDATI.